Why Did Max Healthcare Shares Fall 7% Despite Reporting Strong Q4 Growth?

Synopsis: The share of this hospital company fell 7.3 percent despite reporting strong Q4 FY26 growth, as rising expansion costs and margin pressure weighed on investor sentiment.

The share of this company, which is one of India’s largest private, for-profit healthcare organisations, operating a network of over 20 medical facilities with a total capacity of more than 5,000 beds, gained investors’ attention after a strong Q4.

With a market capitalization of Rs 1,00,697 crore, Max Healthcare Ltd’s shares on Friday made a day low of Rs 1,011.20 per share, down by 7.3 percent from its previous day’s close price of Rs 1,091.95 per share. The share of the company gave a return of 355 percent over the last five years.

Result Overview and Dividend

• QoQ View: The net revenue from operations grew by 2 percent to Rs 2,541 crore in Q4 FY26 from Rs 2,484 crore in Q3 FY26, and Operating EBITDA grew by 5 percent to Rs 682 crore in Q4 FY26 from Rs 648 crore in Q3 FY26. This was accompanied by a net profit (PAT) growth of 12 percent to Rs 387 crore in Q4 FY26 from Rs 344 crore in Q3 FY26.
• YoY View: The net revenue from operations grew by 9 percent to Rs 2,541 crore in Q4 FY26 from Rs 2,326 crore in Q4 FY25, and Operating EBITDA grew by 8 percent to Rs 682 crore in Q4 FY26 from Rs 632 crore in Q4 FY25. This was accompanied by a net profit (PAT) growth of 3 percent to Rs 387 crore in Q4 FY26 from Rs 376 crore in Q4 FY25.
• Fiscal Year Comparison: The net revenue from operations grew by 16 percent to Rs 10,065 crore in FY26 from Rs 8,667 crore in FY25. Annual Operating EBITDA grew by 14 percent to Rs 2,638 crore in FY26 from Rs 2,319 crore in FY25, while the annual net profit (PAT) grew by 22 percent to Rs 1,631 crore in FY26 from Rs 1,336 crore in FY25.

Q4 Business Performance

In Q4 FY26, Max Healthcare Institute reported Network Operating EBITDA of Rs 682 crore, registering an 8 percent YoY growth, while operating margin stood at 26.8 percent compared to 27.2 percent in Q4 FY25. Network PAT increased 3 percent YoY to Rs 387 crore, supported by steady hospital occupancy and improved operational performance across key facilities.

The company’s operational metrics remained healthy during the quarter, with bed occupancy at 75 percent and Occupied Bed Days rising 8 percent YoY. ARPOB stood stable at Rs 77,900, while EBITDA per bed came in at Rs 73.4 lakh. Free cash flow from operations rose sharply to Rs 581 crore compared to Rs 422 crore in Q4 FY25, reflecting strong cash generation.

During Q4 FY26, the company accelerated its expansion strategy through both brownfield and inorganic growth initiatives. It operationalised additional capacity at Max Smart, Mohali, and Nanavati-Max hospitals, while also completing the acquisition of a 58.28 percent stake in Kalinga Hospital Ltd. Additionally, the board approved an investment of around Rs 1,400 crore for a new 712-bed greenfield hospital in Lucknow.

Why can the stock be under pressure after Q4?

Margin Pressure Due to Higher Clinician Costs: Operating margin declined to 26.8 percent in Q4 FY26 from 27.2 percent in Q4 FY25, while clinician costs increased by around 230 bps YoY due to aggressive hiring of medical talent for upcoming capacity additions.

PAT Growth Lagged Revenue Growth: While gross revenue increased 10 percent YoY to Rs 2,664 crore, Network PAT rose only 3 percent YoY to Rs 387 crore, reflecting pressure from higher operating and expansion-related expenses.

EBITDA Per Bed Remained Flat: EBITDA per bed stood at Rs 73.4 lakh in Q4 FY26 compared to Rs 73.9 lakh in Q4 FY25, indicating limited improvement in operational productivity despite higher occupancy and patient volumes.

Large Expansion Plans May Increase Near-Term Spending: The company approved a Rs 1,400 crore investment for a 712-bed Lucknow hospital, while also operationalising new capacities, including a 400-bed Max Smart tower and a 280-bed Nanavati-Max expansion, which could weigh on near-term profitability.

Management commentary: Abhay Soi, Chairman and Managing Director, said the company has commissioned nearly 20 percent additional brownfield capacity across Mohali, Mumbai, and Delhi, while another 10 percent capacity addition is expected through the upcoming Gurgaon greenfield facility by the end of the year.

Management also highlighted that the hospital network delivered its 22nd consecutive quarter of YoY growth, with revenue rising 10 percent and operating EBITDA increasing 8 percent. The company further stated that integration work has already begun for Kalinga Hospital Ltd, alongside expansion and upgradation plans to strengthen healthcare services in Bhubaneswar.

About the Company

Max Healthcare is one of India’s largest private hospital chains, operating over 20 facilities with a capacity exceeding 5,200 beds. Headquartered in New Delhi and led by Chairman and Managing Director Abhay Soi, the network primarily serves Metro and Tier-1 cities across North and West India.\

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.

The post Why Did Max Healthcare Shares Fall 7% Despite Reporting Strong Q4 Growth? appeared first on Trade Brains.